The trouble with all of these 100% numbers is that very few people (in either group of trial participants) were hospitalised. We have a small sample for the es

The trouble with all of these 100% numbers is that very few people (in either group of trial participants) were hospitalised. We have a small sample for the estimate of this efficacy. That being said, all the vaccines have shown this in small samples, so my current working theory is that the hospitalisation rates post vaccine will be very, very low (but almost certainly not 0%).